* 为制药公司代工研发药物的中国康龙化成H股3759.HK周一早盘高开2%，随后涨幅扩大至5.6%，报22.9港元，其A股300759.SZ亦一度升4%。
* 美国投行富瑞在报告中表示，将康龙化成H股的目标价由22港元上调至28港元，预计中国实验室服务业务将从下半年开始复苏，得益于中国生物科技公司的出海授权热潮。
* 康龙化成H股今年迄今劲涨59.7%，同期恒生指数.HSI大幅上扬28.8%。
* 恒生香港上市生物科技指数.HSHKBIO盘中一度升1.5%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 张喜良)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.